English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Urinary bladder cancer represents the seventh most common cancer worldwide; the most common type of bladder cancer is urothelial carcinoma (1). About 75% of patients are initially diagnosed with non-muscle-invasive bladder cancer (NMIBC), whose treatment includes a surveillance regimen based on risk stratification for recurrence and progression (1,2). The need for intensive and long-term follow-up, mainly represented by cystoscopic examinations with biopsies, makes bladder cancer the most expensive cancer to treat (3).

Predicting the biological behavior of non-muscle-invasive bladder cancer: from histology to molecular taxonomy